Better Obesity Drug Race: Novo Nordisk vs Lilly 2026
In the race to dominate obesity drugs, Novo Nordisk and Eli Lilly are frontrunners. This guide analyzes who has the e...
Find which retirement index fund has the best fee and how this impacts your overall returns. Learn to spot the true cost leaders.
28,127 articlesIn the race to dominate obesity drugs, Novo Nordisk and Eli Lilly are frontrunners. This guide analyzes who has the e...
Famed investor Michael Burry reportedly tacks a bearish stance onto Micron Technology, signaling renewed caution for ...
The chip market has cooled as investors weigh AI infrastructure costs. This piece highlights three AI chip stocks to ...
Disney has debated separating its Parks division as the media world reshapes itself. This article explains whether a ...
Marvell Technology tumbles on revised AI capex forecasts, intensifying a wider retreat in semiconductor names. Major ...
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Hydrogen policy momentum and rising costs are shaping a wide range of outcomes for plug power (plug) stock, with anal...
Robinhood just announced a substantial $1.5 billion buyback. In this analysis, we weigh the potential benefits agains...
Investors are buzzing about great news amazon stock as Amazon leans into cloud, ads, and AI. This guide explains the ...
Oracle stock faces a pivotal moment as management doubles down on AI infrastructure while financing plans raise dilut...
Jamie Dimon just turned 70, and a brush with a life-threatening health crisis years ago reshaped his view of success,...
Famed investor Michael Burry considered betting against SpaceX after its IPO but ultimately stayed neutral. The stock...